SE7407913L - - Google Patents

Info

Publication number
SE7407913L
SE7407913L SE7407913A SE7407913A SE7407913L SE 7407913 L SE7407913 L SE 7407913L SE 7407913 A SE7407913 A SE 7407913A SE 7407913 A SE7407913 A SE 7407913A SE 7407913 L SE7407913 L SE 7407913L
Authority
SE
Sweden
Prior art keywords
groups
carbon atoms
atom
oxoalkyl
carbon atom
Prior art date
Application number
SE7407913A
Other languages
English (en)
Other versions
SE423631B (sv
Inventor
W Mohler
M Jayme
J Komarek
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SE7407913L publication Critical patent/SE7407913L/xx
Publication of SE423631B publication Critical patent/SE423631B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7407913A 1973-06-16 1974-06-14 Forfarande for framstellning av oxaalhyl-dialkylxantiner SE423631B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2330742A DE2330742C2 (de) 1973-06-16 1973-06-16 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
SE7407913L true SE7407913L (es) 1974-12-17
SE423631B SE423631B (sv) 1982-05-17

Family

ID=5884209

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7407913A SE423631B (sv) 1973-06-16 1974-06-14 Forfarande for framstellning av oxaalhyl-dialkylxantiner

Country Status (17)

Country Link
US (1) US4289776A (es)
JP (1) JPS5233120B2 (es)
AR (3) AR208179A1 (es)
AT (1) AT334388B (es)
BE (1) BE816332A (es)
CH (2) CH608807A5 (es)
DE (1) DE2330742C2 (es)
DK (1) DK145676C (es)
ES (1) ES427171A1 (es)
FI (1) FI58920C (es)
FR (1) FR2233065B1 (es)
GB (1) GB1470220A (es)
IE (1) IE39898B1 (es)
NL (1) NL182806C (es)
NO (1) NO140300C (es)
SE (1) SE423631B (es)
ZA (1) ZA743760B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH608236A5 (es) 1974-01-22 1978-12-29 Wuelfing J A Fa
DE2507554A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2507555A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
JPS54112893A (en) * 1978-02-21 1979-09-04 Kohjin Co Ltd Preparation of 1-(5'-oxohexyl)-3,7-diethylxanthine
DE2967632D1 (en) * 1978-04-22 1986-12-04 Beecham Wuelfing Gmbh & Co Kg Use of a xanthine derivate in the manufacture of a medicament
IL59665A0 (en) * 1979-04-05 1980-06-30 Wuelfing J Kg Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
EP0157098A1 (en) * 1980-06-21 1985-10-09 Beecham Wuelfing GmbH & Co KG Xanthine derivatives, pharmaceuticals compositions containing them and a process for their preparation
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
JPH062675B2 (ja) * 1985-04-05 1994-01-12 ヘキストジヤパン株式会社 記憶障害治療剤
GB8621869D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Treatment
JPS63225317A (ja) * 1986-10-06 1988-09-20 Hoechst Japan Kk 抗消化性潰瘍剤
IT1197516B (it) * 1986-12-24 1988-11-30 Abc Ist Biolog Chem Spa Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5096906A (en) * 1986-12-31 1992-03-17 University Of Virginia Alumni Patents Foundation Method of inhibiting the activity of leukocyte derived cytokines
CA2030112A1 (en) * 1989-11-24 1991-05-25 Yasuo Ito Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
DE3942872A1 (de) * 1989-12-23 1991-06-27 Hoechst Ag Verfahren zur enantioselektiven darstellung von ((omega)-1)-hydroxyalkylxanthinen
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
DE59207086D1 (de) * 1991-05-23 1996-10-17 Hoechst Ag Die Verwendung von 1-(5-Oxohexyl)-3-methyl-7-n-propyl-xanthin in der Gefässchirurgie
MX9203323A (es) * 1991-07-11 1994-07-29 Hoechst Ag El empleo de derivados de xantina para el tratamiento de lesiones secundarias de las celulas nerviosas y trastornos funcionales despues de traumas craneo-cerebrales.
JP2549480B2 (ja) * 1991-12-10 1996-10-30 ヘキストジャパン株式会社 排尿障害改善剤
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US6020337A (en) * 1993-04-05 2000-02-01 Cell Therapeutics, Inc. Electronegative-substituted long chain xanthine compounds
US5670506A (en) * 1993-04-05 1997-09-23 Cell Therapeutics, Inc. Halogen, isothiocyanate or azide substituted xanthines
WO1995020589A1 (en) * 1994-01-28 1995-08-03 Cell Therapeutics, Inc. Cell signaling inhibitors
US5762953A (en) * 1996-08-22 1998-06-09 Theratech, Inc. Transdermal propentofylline compositions for the treatment of Alzheimers disease
DE19707655A1 (de) * 1997-02-26 1998-08-27 Hoechst Ag Kombinationspräparat zur Anwendung bei Demenz
US20040110776A1 (en) * 2002-02-22 2004-06-10 Iok-Hou Pang Use of propentofylline to control intraocular pressure
JP5292413B2 (ja) 2008-02-29 2013-09-18 コンサート ファーマシューティカルズ インコーポレイテッド 置換キサンチン誘導体
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
JP2013503883A (ja) 2009-09-02 2013-02-04 コンサート ファーマシューティカルズ インコーポレイテッド 置換キサンチン誘導体
US11225481B2 (en) * 2015-12-29 2022-01-18 Centre National De La Recherche Scientifique Xanthine derivative inhibitors of BET proteins
CN112724160A (zh) * 2021-03-19 2021-04-30 赤峰经方医药技术开发有限责任公司 一种己酮可可碱杂质的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH325292A (de) * 1953-10-21 1957-10-31 Geigy Ag J R Verfahren zur Herstellung von 7-Oxyalkyl-xanthinderivaten
FR1211333A (fr) * 1955-10-19 1960-03-15 Boehringer Sohn Ingelheim Perfectionnements apportés aux procédés pour fabriquer des oxyalcoylxanthines
DE1545689C2 (de) 1964-09-05 1982-07-01 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von 2-Methyl-3-carbäthoxy-5,6-dihydropyran
US3737433A (en) 1964-09-05 1973-06-05 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines
US3422107A (en) 1964-09-05 1969-01-14 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines and a process for the preparation thereof
DE1233405B (de) 1964-09-05 1967-02-02 Albert Ag Chem Werke Verfahren zur Herstellung von 7-(Oxoalkyl)-1, 3-dimethylxanthinen
DE1810705C3 (de) * 1968-11-25 1980-11-27 Hoechst Ag, 6000 Frankfurt Stabilisierung von Vitaminen
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen

Also Published As

Publication number Publication date
ES427171A1 (es) 1976-07-16
IE39898L (en) 1974-12-16
FI58920C (fi) 1981-05-11
NL182806B (nl) 1987-12-16
FI58920B (fi) 1981-01-30
DK145676C (da) 1983-08-01
FR2233065B1 (es) 1978-07-21
ZA743760B (en) 1975-06-25
US4289776A (en) 1981-09-15
FI181974A (es) 1974-12-17
DK321574A (es) 1975-02-10
CH612969A5 (es) 1979-08-31
NL7407890A (es) 1974-12-18
DK145676B (da) 1983-01-24
FR2233065A1 (es) 1975-01-10
DE2330742C2 (de) 1982-07-29
ATA491874A (de) 1976-05-15
AR209320A1 (es) 1977-04-15
AT334388B (de) 1976-01-10
BE816332A (fr) 1974-12-16
NO140300B (no) 1979-04-30
NO140300C (no) 1979-08-08
AR209319A1 (es) 1977-04-15
SE423631B (sv) 1982-05-17
NL182806C (nl) 1988-05-16
NO742121L (es) 1975-01-13
IE39898B1 (en) 1979-01-31
GB1470220A (en) 1977-04-14
AU7014774A (en) 1975-12-18
AR208179A1 (es) 1976-12-09
DE2330742A1 (de) 1975-01-09
JPS5047992A (es) 1975-04-28
CH608807A5 (es) 1979-01-31
JPS5233120B2 (es) 1977-08-26

Similar Documents

Publication Publication Date Title
SE7407913L (es)
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
ES8605806A1 (es) Procedimiento de preparacion de nuevos derivados de la xan- tina y de sus sales de adicion con acidos apropiados
ES8107185A1 (es) Procedimiento para preparar piperidinas y pirrolidinas sus- tituidas
DE3271269D1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
IL62111A (en) Phenylalkenyl imidazole derivatives,their preparation and pharmaceutical compositions containing them
DE3170937D1 (en) 2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them
ES8101884A1 (es) Procedimiento de obtencion de composiciones cosmeticas
ES8106289A1 (es) Procedimiento de preparacion de nuevos derivados del a-fe- nil-2-pirrolidin-metanol
ES484718A1 (es) Un procedimiento para la preparacion de benzopiranos.
IL70560A (en) Dialkylaminoalkoxybenzyl alcohol derivatives,their preparation and pharmaceutical compositions containing them
EP0047405A3 (en) Azolylalkyl derivatives, process for their preparation and their use as fungicides
IL75987A0 (en) 1,6-naphthyridine derivatives,their preparation and pharmaceutical compositions containing them
ES8301919A1 (es) Procedimiento para preparar derivados de indano
ES471507A1 (es) Procedimiento para la obtencion de piperidino-propanoles
ATE66920T1 (de) Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten.
ES8608873A1 (es) Un procedimiento para la preparacion de nuevas 3-alcoxi-2-(n-pirrolidino)-n-piridiln-furilmetil propilaminas.
ES479440A1 (es) Un procedimiento para preparar compuestos con propiedades broncodilatadoras.
ES8502962A1 (es) Un procedimiento para preparar un derivado de acido bifenililpropionico
ES8603845A1 (es) Procedimiento de preparacion de nuevos derivados a-etilami- noetoxibencilalcoholicos con un grupo fenil sustituido en situacion a y de sus sales de adicion acida y amobica cua- ternaria
GB1500973A (en) Piperidine derivatives
ES473909A1 (es) Procedimiento para la obtencion de derivados del acido ci- clohexil-4 naftaleno-acetico-1
ATE6063T1 (de) Cycloalkano-thiazolyloxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
ES485333A1 (es) Procedimiento para preparar derivados 5,6,7,8-tetrahidro-4 (3h)-quinazolinonicos y sus sales
ES2009283A6 (es) Procedimiento para preparar nuevos aminoacilatos de glicerol-acetal.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7407913-8

Effective date: 19940710

Format of ref document f/p: F